Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 3, 2010, Pages 648-654

  Graves, Kristi D ^a   Wenzel, Lari ^c   Schwartz, Marc D ^a   Luta, George ^b   Wileyto, Paul ^d   Narod, Steven ^f   Peshkin, Beth N ^a   Marcus, Alfred ^g   Cella, David ^h   Emsbo, Susan Powell ^g   Barnes, Denise ^g   Halbert, Chanita Hughes ^e  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g WOMEN S COLLEGE HOSPITAL   (Canada)

^h UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MENTAL STRESS; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL TELEPHONE COUNSELING; RANDOMIZED CONTROLLED TRIAL; TELECONSULTATION;

FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; TELEPHONE;

EID: 77949766281     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0548     Document Type: Article

References (35)

1. Nusbaum R, Isaacs C. Management updates for women with a BRCA1 or BRCA2 mutation. Mol Diagn Ther 2007;11:133-44.
2. Coyne JC, Benazon NR, Gaba CG, Calzone K, Weber BL. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. J Consult Clin Psychol 2000;68:864-74.
3. Hamilton JG, Lobel M, Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 2009;28:510-8.
4. Palmer SC, Kagee A, Kruus L, Coyne JC. Overemphasis of psychological risks of genetic testing may have "dire" consequences. Psychosomatics 2002;43:86-7.
5. Schwartz MD, Peshkin BN, Hughes C, et al. Impact of BRCA1/ BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002;20:514-20.
6. Cella D, Hughes C, Peterman A, et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002;21:564-72.
7. Dorval M, Patenaude AF, Schneider KA, et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 2000;18:2135-42.
8. Tercyak KP, Lerman C, Peshkin BN, et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol 2001;20:217-22.
9. Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB. Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis 2006;27:97-108.
10. Slovic P, Peters E, Finucane ML, Macgregor DG. Affect, risk, and decision making. Health Psychol 2005;24:S35-40.
11. Schwartz MD, Peshkin BN, Tercyak KP, Taylor KL, Valdimarsdottir H. Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychol 2005;24:S78-84.
12. Graves KD, Peshkin BN, Halbert CH, et al. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 2007;104:321-9.
13. Kenen RH, Shapiro PJ, Friedman S, Coyne JC. Peer-support in coping with medical uncertainty: discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psychooncology 2007;16:763-71.
14. O'Neill SC, DeMarco T, Peshkin BN, et al. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet C Semin Med Genet 2006;142C:251-9.
15. Charles S, Kessler L, Stopfer JE, Domchek S, Halbert CH. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns 2006;63: 196-204.
16. McInerney-Leo A, Biesecker BB, Hadley DW, et al. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. Am J Med Genet A 2004;130A:221-7.
17. Miller SM, Roussi P, Daly MB, et al. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Educ Behav 2005; 32:654-67.
18. Schwartz MD, Valdimarsdottir HB, Demarco TA, et al. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction. Health Psychol 2009; 28:11-9.
19. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer Publishing Company; 1984.
20. Halbert CH, Wenzel L, Lerman C, et al. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2004;13:875-81.
21. Hughes C, Lerman C, Schwartz M, et al. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002;107:143-50.
22. Marcus AC, Garrett KM, Kulchak-Rahm A, et al. Telephone counseling in psychosocial oncology: a report from the Cancer Information and Counseling Line. Patient Educ Couns 2002;46:267-75.
23. Halbert CH, Schwartz MD, Wenzel L, et al. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med 2004;27:373-92.
24. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15.
25. Sandanger I, Moum T, Ingebrigtsen G, et al. The meaning and significance of caseness: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview. II. Soc Psychiatry Psychiatr Epidemiol 1999;34:53-9.
26. Edgell SE, Noon SM. Effect of violation of normality on the t test of the correlation coefficient. Psychol Bull 1984;95:576-83.
27. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997;16:2529-42.
28. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold; 2000.
29. Daly MB, Barsevick A, Miller SM, et al. Communicating genetic test results to the family: a six-step, skills-building strategy. Fam Community Health 2001;24:13-26.
30. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
31. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
32. Peshkin BN. Breast cancer risk assessment and genetic testing: complexities, conundrums, and community. Breast Dis 2006;27:1-3.
33. Peshkin BN, Demarco TA, Graves KD, et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test 2008;12:37-52.
34. Esplen MJ, Toner B, Hunter J, et al. A supportive-expressive group intervention for women with a family history of breast cancer: results of a phase II study. Psychooncology 2000;9:243-52.
35. 23andMe. Retrieved September 25, 2009 from URL: https://www.23andme.com [Online]. 2009.